Caption Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Caption Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $184,323 - $336,189	-23,692 Reduced 99.87%	30 $0
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $180,049 - $414,423	23,722 New	23,722 $351,000
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $1.7 Million - $3.36 Million	382,200 Added 4900.0%	390,000 $1.77 Million
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $43,134 - $64,116	7,800 New	7,800 $47,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $304,988 - $419,559	-32,003 Reduced 85.57%	5,397 $52,000
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $211,975 - $609,014	-33,225 Reduced 47.04%	37,400 $413,000
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $680,502 - $1.14 Million	41,118 Added 139.35%	70,625 $1.35 Million
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $376,332 - $492,468	-18,493 Reduced 38.53%	29,507 $728,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $1.59 Million - $3.21 Million	-97,200 Reduced 66.94%	48,000 $1.25 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $2.81 Million - $5.58 Million	143,600 Added 8975.0%	145,200 $4.35 Million
Q4 2019 Feb 13, 2020	SELL	$17.95 - $29.41 $703,640 - $1.15 Million	-39,200 Reduced 96.08%	1,600 $44,000
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $1.42 Million - $2.05 Million	-78,800 Reduced 65.89%	40,800 $743,000
Q2 2019 Aug 13, 2019	BUY	$9.78 - $24.52 $1.17 Million - $2.93 Million	119,600 New	119,600 $2.93 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.